Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03333161 · ClinicalTrials.gov registry record · NA
Prematurity Related Ventilatory Control (PRE-VENT) - Specific Aim 2
A NA study of Infant, Premature, sponsored by University of Alabama at Birmingham.
- Completed
- Registry status
- NA
- Development phase
- 25
- Enrollment target
- 1
- Study location
NCT03333161: Completed NA study of Infant, Premature, sponsored by University of Alabama at Birmingham.
NCT03333161 is a NA study of Infant, Premature that has completed, run by University of Alabama at Birmingham. The registered enrollment target is 25 participants, below the 9,885-participant average among 16 other Infant, Premature trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03333161, a NA study of Infant, Premature, has completed, sponsored by University of Alabama at Birmingham.
- COMPLETED
- Registry status
- NA
- Development phase
- 25 participants
- Enrollment target
- 1
- Study location
Study Summary
To determine if late (at or beyond postnatal day 14) mild permissive hypercapnia is associated with reduction in apnea, bradycardia, and hypoxemic episodes and with improved stability of oxygenation.
Primary Outcome
Hypoxemic episode defined as as oxygen saturation by pulse oximetry (SpO2 )\<85% for \>10 seconds
Conditions Studied
Interventions
- DIAGNOSTIC_TEST Cardiorespiratory monitoring
Study Locations (1)
Alabama
- Regional Neonatal ICU and CCN, University of Alabama at Birmingham - Birmingham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2018-04-09 |
| Est. Completion | 2021-03-30 |
| Phase | NA |
What the finished NCT03333161 record still lists
NCT03333161 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 25 participants, a relatively small participant target, below the 9,885-participant average among 16 other Infant, Premature trials with a reported enrollment target (100% lower).
The record links to 1 condition, with Infant, Premature appearing as the primary indexed condition, and to 1 intervention - of which Cardiorespiratory monitoring is the first listed.
NCT03333161 reports a single indexed study location in Alabama.
Frequently Asked Questions
What is clinical trial NCT03333161 about?
NCT03333161 is a clinical study titled "Prematurity Related Ventilatory Control (PRE-VENT) - Specific Aim 2". To determine if late (at or beyond postnatal day 14) mild permissive hypercapnia is associated with reduction in apnea, bradycardia, and hypoxemic episodes and with improved stability of oxygenation.
What is the current status of trial NCT03333161?
This trial is currently completed. It is a NA study. The enrollment target is 25 participants. The study started on 2018-04-09. Estimated completion is 2021-03-30.
What conditions does trial NCT03333161 study?
This clinical trial studies the following conditions: Infant, Premature.
What interventions are being tested in trial NCT03333161?
The interventions under investigation include: Cardiorespiratory monitoring (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT03333161?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03333161 being conducted?
This trial has 1 study location across Alabama. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Infant, Premature
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03333161's enrollment target sits among peer trials
25 17th of 16 the lowest of 16 other Infant, Premature trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Infant, Premature trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Serial Assessment of Body Fat Accrual in Very Preterm Infants
ACTIVE NOT RECRUITING · NA
-
Determining an Optimal Weaning Method of Nasal Continuous Positive Airway Pressure in Preterm Neonates
COMPLETED · NA
-
Randomized Controlled Trial of Higher-Volume Feedings in Preterm Neonates
COMPLETED · NA
-
Generic Database of Very Low Birth Weight Infants
RECRUITING
-
Follow-up Visit of High Risk Infants
RECRUITING
-
Management of the PDA Trial
ACTIVE NOT RECRUITING · Phase 3
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01166854 · 25 participants
Characterization of Familial Myopathy and Paget Disease of Bone
- NCT01913106 · 25 participants · Phase 1
HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer
- NCT02138669 · 25 participants · NA
Intacs Prescription Inserts for Keratoconus Patients
- NCT02174549 · 25 participants · Phase 1
Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI